Long-term gamma transcranial alternating current stimulation improves the memory function of mice with Alzheimer’s disease

Long-term gamma transcranial alternating current stimulation improves the memory function of mice with Alzheimer’s disease

BackgroundThe main manifestation of Alzheimer’s disease (AD) in patients and animal models is impaired memory function, characterized by amyloid-beta (Aβ) deposition and impairment of gamma oscillations that play an important role in perception and cognitive function. The therapeutic effect of gamma...

Full description

Bibliographic Details
Main Authors:	Linyan Wu, Tiantian Cao, Sinan Li, Ye Yuan, Wenlong Zhang, Liang Huang, Chujie Cai, Liming Fan, Long Li, Jingyun Wang, Tian Liu, Jue Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Aging Neuroscience
Subjects:	APP/PS1 hippocampus transcranial alternating current stimulation microglia beta-amyloid
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2022.980636/full

Similar Items

Transcranial Alternating Current Stimulation Improves Memory Function in Alzheimer’s Mice by Ameliorating Abnormal Gamma Oscillation
by: Linyan Wu, et al.
Published: (2023-01-01)

Improving the Effect of Transcranial Alternating Current Stimulation (tACS): A Systematic Review
by: Linyan Wu, et al.
Published: (2021-06-01)

Effects of Qi-Fu-Yin on aging of APP/PS1 transgenic mice by regulating the intestinal microbiome
by: Qiu-yue Xiao, et al.
Published: (2023-01-01)

Osthole/borneol thermosensitive gel via intranasal administration enhances intracerebral bioavailability to improve cognitive impairment in APP/PS1 transgenic mice
by: Fanchang Wu, et al.
Published: (2023-07-01)

YXQN Reduces Alzheimer’s Disease-Like Pathology and Cognitive Decline in APPswePS1dE9 Transgenic Mice
by: Xiaowan Wang, et al.
Published: (2017-05-01)

Repeated anodal high-definition transcranial direct current stimulation over the left dorsolateral prefrontal cortex in mild cognitive impairment patients increased regional homogeneity in multiple brain regions.
by: Fangmei He, et al.
Published: (2021-01-01)

Yizhiqingxin Formula Alleviates Cognitive Deficits and Enhances Autophagy via mTOR Signaling Pathway Modulation in Early Onset Alzheimer’s Disease Mice
by: Yang Yang, et al.
Published: (2019-09-01)

Aspirin curcumin ester loaded biomimetic nanodrug improves cognitive deficits in a mouse model of Alzheimer's disease by regulating M1/M2 microglial polarization
by: Ze Li, et al.
Published: (2022-12-01)

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling
by: Lei Li, et al.
Published: (2020-02-01)

Protective Effects of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Isolated from Averrhoa Carambola L. (Oxalidaceae) Roots on Neuron Apoptosis and Memory Deficits in Alzheimer's Disease
by: Xiaojie Wei, et al.
Published: (2018-09-01)

Intermittent hypoxia improves cognition and reduces anxiety‐related behavior in APP/PS1 mice
by: Sheng‐Xi Meng, et al.
Published: (2020-02-01)

Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
by: Oksana Fihurka, et al.
Published: (2023-01-01)

The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC
by: Oksana Fihurka, et al.
Published: (2022-04-01)

Effects of multi-mode physical stimulation on APP/PS1 Alzheimer's disease model mice
by: Shupeng Liu, et al.
Published: (2022-12-01)

Activation of the brain during motor imagination task with auditory stimulation
by: Long Li, et al.
Published: (2023-03-01)

Molecular Biology of Alzheimer’s Disease
by: M. Baki Yokeş, et al.
Published: (2005-04-01)

Multifunctional Gomisin B enhances cognitive function in APP/PS1 transgenic mice by regulating Aβ clearance and neuronal apoptosis
by: Jinman Liu, et al.
Published: (2023-10-01)

N-linoleyltyrosine exerts neuroprotective effects in APP/PS1 transgenic mice via cannabinoid receptor-mediated autophagy
by: Chun-mei Long, et al.
Published: (2021-12-01)

Paeonol administration alleviates cognitive deficits and attenuates neural pathological changes in APP/PS1 mice
by: Shengxi Meng, et al.
Published: (2021-12-01)

Pathological and Synaptic Morphological Changes of the Olfactory Bulb in APP/PS1 Model Mice at Different Ages and the Intervention Effect of Memantine
by: LIU Jiani, et al.
Published: (2022-06-01)

Ginsenoside Rk3 ameliorates Aβ-induced neurotoxicity in APP/PS1 model mice via AMPK signaling pathway
by: Lingyu She, et al.
Published: (2023-02-01)

TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
by: Stephani A. Davis, et al.
Published: (2017-07-01)

Anti-Alzheimers molecular mechanism of icariin: insights from gut microbiota, metabolomics, and network pharmacology
by: Yuqing Liu, et al.
Published: (2023-04-01)

Exposure to fluoride aggravates the impairment in learning and memory and neuropathological lesions in mice carrying the APP/PS1 double-transgenic mutation
by: Kun Cao, et al.
Published: (2019-04-01)

Suan-Zao-Ren Decoction ameliorates synaptic plasticity through inhibition of the Aβ deposition and JAK2/STAT3 signaling pathway in AD model of APP/PS1 transgenic mice
by: Qing-Hua Long, et al.
Published: (2021-01-01)

Ceftriaxone Suppresses Group II Metabotropic Glutamate Receptor Expression Contributing to Reversal of Recognition Memory Deficits of Amyloid Precursor Protein/Presenilin 1 AD Mice
by: ShuJuan Fan, et al.
Published: (2022-07-01)

Impact of user-generated travel posts on travel decisions: A comparative study on Weibo and Xiaohongshu
by: Zhuoli Wang, et al.
Published: (2022-11-01)

Cerebroprotein hydrolysate attenuates neurodegenerative changes in Alzheimer’s mice model via ferroptosis pathway
by: Moxi Chen, et al.
Published: (2023-04-01)

Long-term exercise training inhibits inflammation by suppressing hippocampal NLRP3 in APP/PS1 mice
by: Xue Li, et al.
Published: (2023-12-01)

Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models
by: Ming Chen, et al.
Published: (2021-03-01)

Novel method for collecting hippocampal interstitial fluid extracellular vesicles (EVISF) reveals sex‐dependent changes in microglial EV proteome in response to Aβ pathology
by: Morgan C. Pait, et al.
Published: (2024-01-01)

The longitudinal neural dynamics changes of whole brain connectome during natural recovery from poststroke aphasia
by: Liming Fan, et al.
Published: (2022-01-01)

The neuroprotective effects of Liuwei Dihuang medicine in the APP/PS1 mouse model are dependent on the PI3K/Akt signaling pathway
by: Ye Yuan, et al.
Published: (2023-10-01)

Trichostatin A relieves anxiety-and depression-like symptoms in APP/PS1 mice
by: Qiang Su, et al.
Published: (2024-03-01)

Overexpression of LIMK1 in hippocampal excitatory neurons improves synaptic plasticity and social recognition memory in APP/PS1 mice
by: Haiwang Zhang, et al.
Published: (2021-07-01)

Fluoxetine Promotes Hippocampal Oligodendrocyte Maturation and Delays Learning and Memory Decline in APP/PS1 Mice
by: Feng-lei Chao, et al.
Published: (2021-01-01)

Loss of Extrasynaptic Inhibitory Glycine Receptors in the Hippocampus of an AD Mouse Model Is Restored by Treatment with Artesunate
by: Jochen Kuhse, et al.
Published: (2023-02-01)

Xueshuantong Improves Functions of Lymphatic Ducts and Modulates Inflammatory Responses in Alzheimer’s Disease Mice
by: Rui Zheng, et al.
Published: (2021-09-01)

Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway
by: Zhang P, et al.
Published: (2023-01-01)

Effect of soluble amyloid precursor protein-alpha on adult hippocampal neurogenesis in a mouse model of Alzheimer’s disease
by: Shane M. Ohline, et al.
Published: (2022-01-01)